Pages
-
Recent Blog Posts
Themes
ABC ACCC advertisments AHPRA AMHC AMI Blackmores CHC Chiropractic Board chiropractors Code authorisation Complaint Resolution Panel consumers CRP Dr Jacqui Forrester Dr Tom Goyer FSANZ Geoff Jowett Gerald Quigley HAIAP Health Practitioner Regulation National Law Act health professionals homeopathic medicines La Trobe University Medicines Australia MMD Review Monash University MWI Pharmacare Laboratories promotion Regulation Reform Regulatory Reform self-regulation Senate Community Affairs Legislation Committee Souvenaid Swisse Swisse Vitamins TGA TGACC Therapeutic Goods Act Therapeutic Goods Advertising Code Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017 Transparency U3A UndoitArchives
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- January 2015
- December 2014
- November 2014
- October 2014
- July 2014
- March 2014
- February 2014
- January 2014
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- May 2012
- April 2012
- March 2012
- June 2011
Category Archives: Pharmaceutical Promotion
Channel Nine ACA ADHD breakthrough; TGA response to FOI
For Background see: https://croakey.org/a-current-affairs-adhd-breakthrough-bona-fide-news-or-unethical-advertising/ On 27 March 2018, following FOI requests, the TGA confirmed that their Advertising Compliance Unit (ACU) did investigate a complaint about this program submitted by Prof Jon Jureidini to the Complaint Resolution Panel on 21 February 2017 … Continue reading
Therapeutic Goods Amendment Bill 2017 passed by Senate
This Bill was passed this morning (15/02/2018) by the Senate with the Labor supporting a Government amendment to continue advertising pre-approval (in mainstream media) for 2 years with a review after 18 months. The Government and Labor did not support … Continue reading
Complementary medicines: The Peoples Choice?
An article in AJP asks, ‘Are complementary medicines conventional medicine’s inferior cousin or a key player in health?‘ The arguments put forward in this article in favor of complementary medicines are: They are frequently purchased by consumers (which fails to … Continue reading
More Publicity on the Therapeutic Goods Amendment Bill 2017
‘Softens hardness’: TGA under fire for health claim list that critics say endorses pseudoscience New list of permitted advertising lines for complementary medicine products does little to protect consumers ‘The Project’ (09/02/2018) also had a hilarious segment on TGA traditional indication craziness. … Continue reading
Government machinations: Therapeutic Goods Amendment Bill 2017
I have reported previously on the Senate inquiry on this Bill and the public forum held to discuss civil society concerns (which TGA staff were instructed not to attend). The report of the Government controlled Senate Committee recommended that the … Continue reading
Posted in Complementary medicine, Medicine policy, Natural Therapies, Pharmaceutical Promotion
Tagged advertisements, Greens, Health Minster Hunt, Labor Party, Permitted Indications, pre-approval, Regulatory Reform, Senate Community Affairs Legislation Committee, Senator Di Natale, TGA, Therapeutic Goods Advertising Code, Transparency
Leave a comment
Monash School of Public Health & Preventive Medicine Students: A Tribute
An end of year tribute to the Monash SPHPM students I’ve been engaged with, especially those who worked with me on the Summer Vacation Scholarship Program and those who presented at the Victorian Skeptics meeting on 18 December, 2017. … Continue reading
Therapeutic Goods Amendment (2017 Measures No. 1) Bill now sent to Senate
This is a win! The Department of Health, TGA and the Health Minister’s Office have been trying to bypass the Senate Committee system on this Bill arguing that it was non-controversial! Which it is not! Fortunately, Greens … Continue reading
TGA provides complementary medicine industry with “Get Out of Jail Free card”
The TGA have recently given approval (under section 42DF of the Therapeutic Goods Act 1989) for a restricted advertising representation by The Tomato Pill Company for Ateronon XY Pro: “Saw Palmetto is traditionally used in herbal medicine to help relieve the … Continue reading
Posted in Complementary medicine, Natural Therapies, Pharmaceutical Promotion
Tagged AHPRA, Ateronon XY Pro; Go Vita; Restricted representation approval; traditional use; s.133 National Law, Complaint Resolution Panel, Dr Ross Walker, Senate Standing Committees on Community Affairs, TGA, TGA funding, TGACC, Therapeutic Goods Advertising Code, Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017, Tomato Pill Company
1 Comment
TGA Consultation Submissions: Regulatory reform of complementary medicines and advertising
The regulatory framework for advertising therapeutic goods Reforms to the regulatory framework for complementary medicines – assessment pathways Options for the future regulation of “low-risk” products Draft List of Permitted Indications Therapeutic Goods Advertising Code See also: Australian patients vulnerable … Continue reading
Concerns about the Exposure Draft of Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017
See the paper: “Concerns about the Exposure Draft of Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017” See also submissions to TGA Consultations on “regulatory reform” by